“While personalized supplement protocols have been game-changing, it’s essential to recognize that conducting follow-ups and making regular dose adjustments are equally crucial aspects of patient care. The team behind Evinature recognize every customer need for emotional support and a credible source of medical information, leading to the inception of Clinic Support.”
Evinature’s Clinic Support Introduces A New Era of Gut Care
“This collaboration demonstrates Adacyte´s strategy of leveraging our expertise in gut health to continue providing innovative and distinctive solutions. We believe even more strongly that Evinature´s unique compound, CurQD, can become a fundamental plan option for customers and physicians struggling to control Gut Health challenges.”
Christian Izcara, Managing Director at Adacyte.
“Using their gold standard in providing each customer with a tailor-fit solution, Evinature goes through an academically rigorous peer review process to ensure the validity of traditional approach. Evinature has gone leaps and bounds further into proving misconceptions about traditional medicine with the ultimate goal of prioritising global accessibility for patients who could not afford treatment otherwise.”
Promising Strategies to Improve Customers Quality of Life
“Sheba is very appreciative of the advanced research ongoing in the GI Department to explore herbal-based innovative strategies to help consumers with chronic disorders, and we are excited that we are now able to provide these solutions to customers worldwide through the Sheba spinoff company, Evinature”
Yoel Har-Even, Director of Sheba Global
“A well designed and thoughtful study that reflects the growing interest in exploring non immunosuppressive approaches through rigorous research. The findings add meaningful insight to this developing area.”
Ashwin N. Ananthakrishnan, MBBS, MPH, Massachusetts General Hospital.
“These results are certainly encouraging. It will be important to see how consistently they can be replicated in future studies and how different groups within the Gut Care community may respond.”
Byron Vaughn, MD, associate professor of medicine & co-director of the IBD program, University of Minnesota.
